Analyst Comments, Analyst EPS View, Analyst PT Change

Analysts Sees Synergies and Struggles in AngioDynamics' (ANGO) Latest Acquisition

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. APGE

6. MU
7. DFTX
8. LCO
9. KR
10. MSTR

Get Alerts ANGO Hot Sheet

Price: $12.34 +1.56%

Rating Summary:
8 Buy, 6 Hold, 1 Sell

Rating Trend:

Up

Today's Overall Ratings:
Up: 17 | Down: 10 | New: 23

Join SI Premium – FREE

AngioDynamics (NASDAQ: ANGO) recently reported first quarter earnings, with revenue in line with guidance. ANGO also announced the acquisition of Vortex Medical.

"On the plus side, we see potentially positive synergies with ANGO's existing PV line. That said, the purchase price was expensive, and we think ANGO's sales reps could be challenged to absorb another product in the near term," said analyst Jason R. Mills of Canaccord Genuity.

Canaccord Genuity maintained a Hold rating on AngioDynamics and cut its price target to $13.50 (from $14.50).

For an analyst ratings summary and ratings history on AngioDynamics click here. For more ratings news on AngioDynamics click here.

Shares of AngioDynamics closed at $12.82 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

Create E-mail Alert Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Earnings, Canaccord Genuity

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!